13 May 2024
Wolters Kluwer Health has joined forces with leading pharmaceutical companies to introduce intuitive and customizable workflows on the Ovid® research platform, setting a new standard for research automation and efficiency.
The collaboration between Wolters Kluwer Health and global pharmaceutical giants aims to address the unique challenges faced by the industry, including managing vast volumes of clinical information across regulatory, clinical writing, medical affairs, pharmacovigilance, health economics and outcomes research, and publications groups. By leveraging automation and efficiency, these customized solutions empower organizations to expedite key tasks such as study design generation, regulatory compliance, and disease management insights.
Enhancing workflow precision and productivity, Ovid medical research solutions deliver targeted search results, drug-specific keywording, and seamless access to relevant research literature. By streamlining administrative processes, teams can allocate more time to essential activities such as stakeholder engagement and regulatory compliance, thereby optimizing research output and impact.
One of the highlights of this collaboration is the development of new enhancements in the Ovid research platform, designed to elevate research automation and efficiency across the pharmaceutical industry. Key updates include:
• Rapid “Find and Replace” Search Updating: Manual updates of proprietary searches are now a thing of the past. Users can swiftly search for specific strings within Saved Searches and AutoAlerts and replace all instances simultaneously, enhancing search accuracy and efficiency.
• AutoAlert Bulk Editing: Simplifying administrative tasks, this feature allows multiple edits to AutoAlerts at once, ensuring timely and relevant information dissemination to stakeholders, even amidst staff turnover or organizational changes.
• Change Audit History: Providing transparency and accountability, this feature logs every change made to AutoAlerts, including run times, edits, and suspensions, along with the user responsible. This robust auditing capability aids in regulation tracking and compliance, safeguarding data integrity and regulatory adherence.
By harnessing the power of Wolters Kluwer’s advanced research technologies and collaborating with global pharmaceutical leaders, the Ovid research platform is poised to revolutionize medical research workflows, driving innovation and efficiency in the quest for groundbreaking medical discoveries. Stay tuned for further advancements and updates as this transformative partnership continues to unfold.